[ad_1]
Washington:
Data from 38,000 trial individuals concerned in testing the Pfizer-BioNTech Covid-19 vaccine revealed “no specific safety concerns,” a doc issued by the US Food and Drug Administration (FDA) stated Tuesday.
The knowledge after two months of follow-up from the second dose of the vaccine “suggest a favorable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization).”
The doc was launched two days earlier than an advisory committee of the FDA meets to determine on emergency approval, and the assertion means that the regulator is inclined to inexperienced gentle the vaccine.
(Except for the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)
[ad_2]
Source hyperlink